The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.
| Image |  |
|---|---|
| Description | scientific article published on 18 May 2009 |
| Author/s |
author: Naoki Yamamoto Jonathan Toma |
| Publication date | May 18, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |